LT2061803T - Fc turinčių baltymų gryninimo būdas - Google Patents

Fc turinčių baltymų gryninimo būdas

Info

Publication number
LT2061803T
LT2061803T LT07802925T LT07802925T LT2061803T LT 2061803 T LT2061803 T LT 2061803T LT 07802925 T LT07802925 T LT 07802925T LT 07802925 T LT07802925 T LT 07802925T LT 2061803 T LT2061803 T LT 2061803T
Authority
LT
Lithuania
Prior art keywords
purification
containing proteins
proteins
Prior art date
Application number
LT07802925T
Other languages
English (en)
Inventor
Alex Eon-Duval
Alain Lamproye
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38610939&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2061803(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of LT2061803T publication Critical patent/LT2061803T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LT07802925T 2006-08-28 2007-08-27 Fc turinčių baltymų gryninimo būdas LT2061803T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06119611 2006-08-28
US84254206P 2006-09-06 2006-09-06
PCT/EP2007/058887 WO2008025748A1 (en) 2006-08-28 2007-08-27 Process for the purification of fc-containing proteins

Publications (1)

Publication Number Publication Date
LT2061803T true LT2061803T (lt) 2019-11-25

Family

ID=38610939

Family Applications (1)

Application Number Title Priority Date Filing Date
LT07802925T LT2061803T (lt) 2006-08-28 2007-08-27 Fc turinčių baltymų gryninimo būdas

Country Status (21)

Country Link
US (1) US8513393B2 (lt)
EP (1) EP2061803B2 (lt)
JP (1) JP2010501623A (lt)
KR (1) KR101770312B1 (lt)
AR (1) AR062570A1 (lt)
AU (1) AU2007291283B2 (lt)
CA (1) CA2661748C (lt)
DK (1) DK2061803T4 (lt)
EA (1) EA017152B1 (lt)
ES (1) ES2755386T5 (lt)
FI (1) FI2061803T4 (lt)
HK (1) HK1131400A1 (lt)
HU (1) HUE045898T2 (lt)
IL (1) IL197220A (lt)
LT (1) LT2061803T (lt)
MX (1) MX2009002014A (lt)
PL (1) PL2061803T5 (lt)
PT (1) PT2061803T (lt)
SI (1) SI2061803T2 (lt)
UA (1) UA99262C2 (lt)
WO (1) WO2008025748A1 (lt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR058568A1 (es) 2005-12-20 2008-02-13 Bristol Myers Squibb Co Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
WO2007076032A2 (en) 2005-12-20 2007-07-05 Bristol-Myers Squibb Company Compositions and methods for producing a composition
DK2061803T4 (da) † 2006-08-28 2022-12-05 Ares Trading Sa Fremgangsmåde til oprensning af fc-holdige proteiner
KR101241486B1 (ko) * 2007-10-30 2013-03-15 제넨테크, 인크. 양이온 교환 크로마토그래피에 의한 항체 정제
TW201028433A (en) * 2008-10-20 2010-08-01 Abbott Lab Viral inactivation during purification of antibodies
EP2346901A1 (en) * 2008-10-20 2011-07-27 Abbott Laboratories Antibodies that bind to il-18 and methods of purifying the same
WO2010141039A1 (en) 2008-10-20 2010-12-09 Abbott Laboratories Isolation and purification of antibodies using protein a affinity chromatography
RU2011120178A (ru) * 2008-10-20 2012-11-27 Эбботт Лэборетриз Антитела, которые связываются с il-12, и способы их очистки
CN107188960A (zh) * 2009-08-07 2017-09-22 Emd密理博公司 从样品的一或多种杂质中纯化靶蛋白的方法
RU2564569C2 (ru) 2009-12-18 2015-10-10 Новартис Аг Промывочный раствор и способ промывки для аффинной хроматографии
WO2011088225A1 (en) 2010-01-15 2011-07-21 Bio-Rad Laboratories, Inc. Surface neutralization of apatite
US8895707B2 (en) * 2010-08-18 2014-11-25 Bio-Rad Laboratories, Inc. Elution of proteins from hydroxyapatite resins without resin deterioration
JP5798307B2 (ja) * 2010-09-03 2015-10-21 国立大学法人名古屋大学 グロボトリアオシルセラミドを特異的に認識するモノクローナル抗体及びその作製法
EP2655412B1 (en) 2010-12-21 2018-01-17 F. Hoffmann-La Roche AG Isoform enriched antibody preparation and method for obtaining it
EP2670704B1 (en) 2011-02-02 2018-12-12 Bio-Rad Laboratories, Inc. Apatite surface neutralization with alkali solutions
CN103547589A (zh) 2011-03-29 2014-01-29 葛兰素史密斯克莱有限责任公司 用于蛋白纯化的缓冲液体系
SG10201701224UA (en) * 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
WO2013180933A1 (en) 2012-05-30 2013-12-05 Bio-Rad Laboratories, Inc. In situ restoration of apatite-based chromatography resins
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
JP6747985B2 (ja) * 2014-06-13 2020-08-26 ルピン アトランティス ホールディングス エスエー ＴＮＦＲ：Ｆｃ融合タンパク質の精製方法
CN105407917B (zh) 2014-06-23 2021-07-06 生物辐射实验室股份有限公司 磷灰石原位恢复
US9802822B2 (en) 2014-06-23 2017-10-31 Bio-Rad Laboratories, Inc. Apatite pretreatment
ES2733298T3 (es) * 2014-07-18 2019-11-28 Sandoz Ag Cuantificación de TNFR2:Fc plegado erróneamente
SG10201908027QA (en) * 2015-03-13 2019-10-30 Bristol Myers Squibb Co Use of alkaline washes during chromatography to remove impurities
PE20230494A1 (es) 2020-05-08 2023-03-23 Alpine Immune Sciences Inc Proteinas inmunomoduladoras inhibidoras de april y baff y metodos de uso de las mismas

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2065346C (en) 1989-09-05 2005-03-29 Craig A. Smith Tumor necrosis factor-.alpha. and-.beta. receptors
US5447851B1 (en) * 1992-04-02 1999-07-06 Univ Texas System Board Of Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
EP0620739A4 (en) 1992-09-15 1997-01-15 Immunex Corp Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists.
ES2129076T5 (es) * 1993-12-27 2003-05-16 Zlb Bioplasma Ag Procedimiento para la preparacion de un concentrado de inmunoglobulina g anti-d y composicion farmaceutica que lo contiene.
US6406901B1 (en) * 1995-06-08 2002-06-18 Immunex Corporation TNF-a converting enzyme
ATE274346T1 (de) 1995-06-08 2004-09-15 Immunex Corp Tnf-alpha konvertierendes enzym
US5969102A (en) 1997-03-03 1999-10-19 St. Jude Children's Research Hospital Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
IL121900A (en) 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
DE69907439T3 (de) * 1998-05-06 2014-01-02 Genentech, Inc. Reinigung von proteinen durch ionenaustauschchromatographie
ATE274522T1 (de) 1998-06-01 2004-09-15 Genentech Inc Abtrennung von antikörper-monomeren von deren multimeren mittels ionaustausch-chromatographie
EP2270044B1 (en) 1998-06-09 2014-11-05 CSL Behring AG Liquid immunoglobulin G (lgG) product
NZ512753A (en) 1999-01-07 2003-10-31 Zymogenetics Inc Soluble receptor BR43x2 related proteins useful for inhibiting ztnf4
DE19955558C2 (de) 1999-11-18 2003-03-20 Stefan Kochanek Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren
US20020086018A1 (en) * 2000-05-12 2002-07-04 Theill Lars Eyde Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI
EA007275B1 (ru) 2001-05-24 2006-08-25 Займодженетикс, Инк. Слитые белки taci-иммуноглобулина
CN103232539B (zh) 2001-06-26 2015-06-03 安姆根弗里蒙特公司 抗opgl抗体
AU2002359816B2 (en) 2001-12-21 2006-07-13 Immunex Corporation Methods for purifying protein
HUE025101T2 (en) 2002-04-26 2016-02-29 Genentech Inc Purification of proteins other than affinity purification
ES2626268T3 (es) 2002-09-11 2017-07-24 Chugai Seiyaku Kabushiki Kaisha Método de purificación de proteínas
IL262513B (en) 2002-09-11 2022-09-01 Genentech Inc Cleaning proteins
DK1601697T3 (da) * 2003-02-28 2007-10-01 Lonza Biologics Plc Oprensning af antistof ved protein A- og ionbytningskromatografi
JPWO2004087761A1 (ja) * 2003-03-31 2006-07-27 麒麟麦酒株式会社 ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
TWI353991B (en) * 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
EP2336172B1 (en) 2003-10-27 2014-12-10 Wyeth LLC Removal of high molecular weight aggregates using hydroxyapatite chromatography
US8846874B2 (en) * 2003-11-13 2014-09-30 Hanmi Science Co., Ltd IgG Fc fragment for a drug carrier and method for the preparation thereof
WO2005100394A2 (en) 2004-04-14 2005-10-27 F. Hoffmann-La Roche Ag PURIFIED INTERLEUKIN-15/Fc FUSION PROTEIN AND PREPARATION THEREOF
KR101482791B1 (ko) 2005-03-11 2015-01-21 와이어쓰 엘엘씨 약한 분배성 크로마토그래피법
NZ562949A (en) * 2005-04-11 2009-05-31 Medarex Inc Protein purification using HCIC and ion exchange chromatography
SG162806A1 (en) * 2005-06-17 2010-07-29 Elan Pharma Int Ltd Methods of purifying anti a beta antibodies
WO2009017491A1 (en) 2006-06-14 2009-02-05 Smithkline Beecham Corporation Methods for purifying antibodies using ceramic hydroxyapatite
DK2061803T4 (da) † 2006-08-28 2022-12-05 Ares Trading Sa Fremgangsmåde til oprensning af fc-holdige proteiner
CA2673771A1 (en) * 2007-01-17 2008-07-24 Merck Serono S.A. Process for the purification of fc-containing proteins

Also Published As

Publication number Publication date
CA2661748C (en) 2016-02-09
KR101770312B1 (ko) 2017-08-22
KR20090057296A (ko) 2009-06-04
EP2061803B2 (en) 2022-11-16
DK2061803T3 (da) 2019-11-18
JP2010501623A (ja) 2010-01-21
ES2755386T5 (es) 2023-04-05
EP2061803B1 (en) 2019-08-14
IL197220A0 (en) 2009-12-24
WO2008025748A1 (en) 2008-03-06
MX2009002014A (es) 2009-03-09
SI2061803T1 (sl) 2019-12-31
IL197220A (en) 2013-06-27
FI2061803T4 (fi) 2023-03-14
HUE045898T2 (hu) 2020-01-28
US20100190961A1 (en) 2010-07-29
PT2061803T (pt) 2019-11-21
ES2755386T3 (es) 2020-04-22
EA200970231A1 (ru) 2009-08-28
SI2061803T2 (sl) 2023-01-31
AU2007291283B2 (en) 2012-09-20
EA017152B1 (ru) 2012-10-30
AR062570A1 (es) 2008-11-19
PL2061803T5 (pl) 2023-03-27
US8513393B2 (en) 2013-08-20
EP2061803A1 (en) 2009-05-27
UA99262C2 (uk) 2012-08-10
HK1131400A1 (en) 2010-01-22
CA2661748A1 (en) 2008-03-06
DK2061803T4 (da) 2022-12-05
AU2007291283A1 (en) 2008-03-06
PL2061803T3 (pl) 2020-02-28

Similar Documents

Publication Publication Date Title
HK1131400A1 (en) Process for the purification of fc-containing proteins
IL199753A0 (en) Process for the purification of fc-containing proteins
ZA200900836B (en) Process for the purification of FC-fusion proteins
EP2054521A4 (en) METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES
EP2226331A4 (en) METHOD OF PURIFYING PROTEINS
IL205107A0 (en) Method for purifying fc-fusion proteins
ZA200708526B (en) Process for the removal of contaminants
IL184184A0 (en) Process for the purification of duloxetine hydrochloride
SI2628746T1 (sl) Proces za koncentriranje polipeptida
IL204949A0 (en) Method for purifying an fc- containing protein
EP1869230A4 (en) PROCESS FOR PURIFYING PROTEINS
ZA200607439B (en) Process for gas purification
EP1960416A4 (en) PROCESS FOR PURIFYING CHENODESOXYCHOLIC ACID
GB0503942D0 (en) Purification process
ZA200900837B (en) Process for the purification of FC-containing proteins
IL184715A0 (en) Process for the preparation of intermediates
PL1973563T3 (pl) Sposób oczyszczania alfa-1-antytrypsyny
GB0624227D0 (en) Protein purification
EP1899375A4 (en) NEW METHOD FOR THE PURIFICATION OF LACTOFERRIN
GB0523257D0 (en) Purification process
EP1966228A4 (en) PURIFICATION METHOD FOR CHENODESOXYCHOLIC ACID
ZA200708802B (en) An improved process for the purification of perindopril
HK1137378A1 (en) Process for the purification of combustion fumes
PL2079758T3 (pl) Sposób oczyszczania DnaK
PL380473A1 (pl) Sposób wytwarzania modyfikowanego kaolinu